A study of a series of 54 patients with PHT (primary, secondary or CTEPH) confirmed, applying multivariate analysis, that elevated titers of LAC or IgG aCL were independent risk factors for the development of CTEPH (92). The gene discussed is ACLY; the disease is chronic thromboembolic pulmonary hypertension.